SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-19-009831
Filing Date
2019-05-30
Accepted
2019-05-30 17:21:26
Documents
10

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ff12019_chinasxtpharma.htm F-1 1389157
2 OPINION OF CAMPBELLS REGARDING THE VALIDITY OF THE ORDINARY SHARES BEING REGISTE ff12019ex5-1_chinasxtpharma.htm EX-5.1 25596
3 CONSENT OF ZH CPA, LLC ff12019ex23-1_chinasxtpharma.htm EX-23.1 3204
4 GRAPHIC img_001.jpg GRAPHIC 29677
5 GRAPHIC img_002.jpg GRAPHIC 87713
6 GRAPHIC img_003.jpg GRAPHIC 31635
7 GRAPHIC img_004.jpg GRAPHIC 21074
8 GRAPHIC img_005.jpg GRAPHIC 51457
9 GRAPHIC image_001.jpg GRAPHIC 5920
10 GRAPHIC image_002.jpg GRAPHIC 3814
  Complete submission text file 0001213900-19-009831.txt   1738364
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: F-1 | Act: 33 | File No.: 333-231839 | Film No.: 19867678
SIC: 2834 Pharmaceutical Preparations